53 related articles for article (PubMed ID: 23477400)
21. Commentary on some recent theses relevant to combating aging: February 2012.
Zealley B; de Grey AD
Rejuvenation Res; 2012 Feb; 15(1):102-7. PubMed ID: 22352437
[No Abstract] [Full Text] [Related]
22. iPSC technology to study human aging and aging-related disorders.
Liu GH; Ding Z; Izpisua Belmonte JC
Curr Opin Cell Biol; 2012 Dec; 24(6):765-74. PubMed ID: 22999273
[TBL] [Abstract][Full Text] [Related]
23. Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes?
Mansilla E; Díaz Aquino V; Zambón D; Marin GH; Mártire K; Roque G; Ichim T; Riordan NH; Patel A; Sturla F; Larsen G; Spretz R; Núñez L; Soratti C; Ibar R; van Leeuwen M; Tau JM; Drago H; Maceira A
Stem Cells Int; 2011; 2011():943216. PubMed ID: 21716667
[TBL] [Abstract][Full Text] [Related]
24. Same function, different origins: multipotent stromal precursors in lymphoid tissues.
Boehm T
Cell Stem Cell; 2013 May; 12(5):501-3. PubMed ID: 23642357
[TBL] [Abstract][Full Text] [Related]
25. Influence of Organismal Aging in Mesenchymal Stem Cell Therapy.
Shabbir A; Suzuki G; Lee T
Am J Biomed Sci Res; 2020; 9(2):105-106. PubMed ID: 33225310
[No Abstract] [Full Text] [Related]
26. Biological Therapies in Regenerative Sports Medicine.
Andia I; Maffulli N
Sports Med; 2017 May; 47(5):807-828. PubMed ID: 27677916
[TBL] [Abstract][Full Text] [Related]
27. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects.
Zhang J; Lian Q; Zhu G; Zhou F; Sui L; Tan C; Mutalif RA; Navasankari R; Zhang Y; Tse HF; Stewart CL; Colman A
Cell Stem Cell; 2011 Jan; 8(1):31-45. PubMed ID: 21185252
[TBL] [Abstract][Full Text] [Related]
28. Towards a Drosophila model of Hutchinson-Gilford progeria syndrome.
Beard GS; Bridger JM; Kill IR; Tree DR
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1389-92. PubMed ID: 19021561
[TBL] [Abstract][Full Text] [Related]
29. Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis.
Bridger JM; Kill IR
Exp Gerontol; 2004 May; 39(5):717-24. PubMed ID: 15130666
[TBL] [Abstract][Full Text] [Related]
30. In vitro pathological modelling using patient-specific induced pluripotent stem cells: the case of progeria.
Nissan X; Blondel S; Peschanski M
Biochem Soc Trans; 2011 Dec; 39(6):1775-9. PubMed ID: 22103524
[TBL] [Abstract][Full Text] [Related]
31. Implications of multipotent mesenchymal stromal cell aging.
Stochaj U; Kodiha M; Shum-Tim D; Colmegna I
Regen Med; 2013 Mar; 8(2):211-22. PubMed ID: 23477400
[TBL] [Abstract][Full Text] [Related]
32. Aging and nuclear organization: lamins and progeria.
Mounkes LC; Stewart CL
Curr Opin Cell Biol; 2004 Jun; 16(3):322-7. PubMed ID: 15145358
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
